Results 41 to 50 of about 11,397 (98)

An acidic patch in the unstructured N-terminus modulates LSD1 activity. [PDF]

Protein Sci
Dukatz F, Timofeev H, Schnee P, Rathert P.   +3 more
europepmc   +1 more source

Targeting oral cancer epigenome via LSD1

Aging, 2017
openaire   +2 more sources

CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma. [PDF]

Cancer Res
Zhang D, Hu J, Zhu G, Liu C, Li G, Lu S, Chen H, Wang X, Yu Z, Yan H, Ding Y, Zhang X, Hou J, Qiu Y, Hung MC, Lu Z, Liu Y.   +16 more
europepmc   +1 more source

CtBP1-LSD1 complex drives ErbB2 activation via H3K9me2 demethylation in DRGs during paclitaxel-induced neuropathic pain. [PDF]

Cell Biol Toxicol
Peng HY, Lai CY, Chen GD, Peng YC, Yeh CM, Lin TB, Wang HH, Cheng JK, Yang PS, Chou CM, Chou D, Lin KH, Nie ST, Hsieh MC.   +13 more
europepmc   +1 more source

ORY1001 enhances anti-tumor immunity via CXCL10-mediated macrophage modulation in EBV-positive DLBCL. [PDF]

Cell Commun Signal
Kim JH, Cho HJ, Yoon SE, Kim WS.
europepmc   +1 more source

Evaluation of [¹⁸F]MNI-1054, a novel PET ligand for lysine-specific histone demethylase 1A (LSD1), in non-human primates. [PDF]

EJNMMI Res
Petibon Y, Takano A, Schwarz AJ, Yardibi O, Sandiego C, Barret O, Constantinescu C, Tauscher J, McQuade P.   +8 more
europepmc   +1 more source

Computational study of chalcone-cyanopyrimidine hybrids as LSD1 inhibitors: Assessing the influence of FAD on binding affinity and inhibition. [PDF]

Biochem Biophys Rep
Saifullah MK, Gupta A, Parveen D, Azam F, Alam MM, Akhter M, Parvez S, Maksud N, Azeez N, Shaquiquzzaman M.   +9 more
europepmc   +1 more source

Regulation of androgen receptor expression by enhancer elements in prostate cancer. [PDF]

Exp Mol Med
Khadka S, Jeon HY, Hussain A, Qi J.
europepmc   +1 more source

Targeting epigenetic methylation: emerging diagnosis and therapeutic strategies in cancer. [PDF]

Exp Hematol Oncol
Zhu Y, Liu K, Zhu H.
europepmc   +1 more source

LSD1 inhibition sensitizes anti-PD1 blockade immunotherapy by inhibiting the long-range attack of tumor-derived extracellular vesicles. [PDF]

Acta Pharm Sin B
Zhao Y, Zhang D, Meng L, Shan S, Zhang C, Deng Z, Han C, Kong L.   +7 more
europepmc   +1 more source